[HTML][HTML] Targeting the epidermal growth factor receptor in addition to chemotherapy in patients with advanced pancreatic cancer: A systematic review and meta …
J Chiramel, AC Backen, R Pihlak, A Lamarca… - International Journal of …, 2017 - mdpi.com
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
[HTML][HTML] Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta …
J Chiramel, AC Backen, R Pihlak… - … Journal of Molecular …, 2017 - ncbi.nlm.nih.gov
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
[PDF][PDF] Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta …
J Chiramel, AC Backen, R Pihlak, A Lamarca… - Int. J. Mol …, 2017 - researchgate.net
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.
J Chiramel, AC Backen, R Pihlak… - … Journal of Molecular …, 2017 - europepmc.org
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
J Chiramel, AC Backen, R Pihlak, A Lamarca… - tspace.library.utoronto.ca
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
[PDF][PDF] Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta …
J Chiramel, AC Backen, R Pihlak… - Int. J. Mol …, 2017 - pdfs.semanticscholar.org
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
J Chiramel, AC Backen, R Pihlak… - International …, 2017 - search.proquest.com
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
J Chiramel, AC Backen, R Pihlak, A Lamarca… - 2017 - agris.fao.org
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
J Chiramel, AC Backen, R Pihlak… - International …, 2017 - pubmed.ncbi.nlm.nih.gov
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
Targeting the epidermal growth factor receptor in addition to chemotherapy in patients with advanced pancreatic cancer: a systematic review and meta-analysis.
J Chiramel, AC Backen, R Pihlak, A Lamarca… - 2017 - christie.openrepository.com
Overexpression of epidermal growth factor receptors (EGFR) occurs in> 90% of pancreatic
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …
ductal adenocarcinomas (PDACs) and is associated with a poorer prognosis. A systematic …